Treace Medical Concepts, Inc. (TMCI) Cash Flow Statement
Treace Medical Concepts, Inc. (TMCI) generated -$14.6M of operating cash flow over the twelve months to 2026-06-30, spent $10.5M on capital expenditure and had free cash flow of -$25.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMCITreace Medical Concepts, Inc.Follow TMCI — free
—
Price chart with a free account
- Market cap
- 277.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 16 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -17.2 | -30.6 | -34.6 | -37.2 | -16.0 | -14.6 | |
| Capital expenditure | 2.7 | 14.8 | 11.5 | 11.6 | 13.5 | -10.5 | |
| Free cash flow | -19.9 | -45.5 | -46.0 | -48.8 | -29.5 | -25.0 | |
| Stock-based compensation | 3.4 | 8.1 | 17.4 | 30.6 | 33.8 | — |
USD millions · SEC XBRL
Treace Medical Concepts, Inc. — questions
- What is Treace Medical Concepts, Inc.'s operating cash flow?
- -$14.6M over the twelve months to 2026-06-30.
- How much does Treace Medical Concepts, Inc. spend on capital expenditure?
- $10.5M over the twelve months to 2026-06-30.
- What is Treace Medical Concepts, Inc.'s free cash flow?
- -$25.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Treace Medical Concepts, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.